← FDA DRUG APPROVALS

FDA ANDA · ANDA040870

METHIMAZOLE

Sponsor: SUN PHARM INDS INC

APPLICATION
ANDA040870
TYPE
ANDA
ORIGINAL APPROVAL
2007-09-25
LATEST ACTION
2019-01-18
ROUTE
ORAL
DOSAGE FORM
TABLET
MARKETING STATUS
Discontinued

Products

METHIMAZOLEDiscontinued
METHIMAZOLE 5MG · TABLET · ORAL
METHIMAZOLEDiscontinued
METHIMAZOLE 10MG · TABLET · ORAL

Approval history

2019-01-18Labeling · Supplement 8 · standardAP
2016-01-15Labeling · Supplement 7 · standardAP
2007-09-25OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industry →GMP discipline →FDA drug shortages →FDA enforcement & recalls →

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →